Home

Wütend Krise Das Layout valeant short Amüsement Fein Elektriker

What the Average Short Position in Valeant
What the Average Short Position in Valeant

Short Sellers Don't Exist to Fix the Problems. They Exist to Shed Light on  the Problems” - ProMarket
Short Sellers Don't Exist to Fix the Problems. They Exist to Shed Light on the Problems” - ProMarket

Valeant scandal shows why we need short-sellers in the stock market - Los  Angeles Times
Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times

Short Seller Says Valeant Uninvestable
Short Seller Says Valeant Uninvestable

Short-Seller Chanos Turns Attention to Valeant - The New York Times
Short-Seller Chanos Turns Attention to Valeant - The New York Times

Valeant shares recoup losses after company rejects short seller report -  MarketWatch
Valeant shares recoup losses after company rejects short seller report - MarketWatch

Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg
Watch Safkhet Capital's Quadir Is Still Short Valeant - Bloomberg

The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg
The Anti-Ackman: Valeant Short Sellers Have Made $2.8 Billion - Bloomberg

Exclusive: SEC probe of Valeant began with review of short seller - sources  | Reuters
Exclusive: SEC probe of Valeant began with review of short seller - sources | Reuters

Short Seller Who Foresaw Valeant Crash Now Bets on Tesla Drop - Video - BNN
Short Seller Who Foresaw Valeant Crash Now Bets on Tesla Drop - Video - BNN

Valeant Pharmaceuticals' Dizzying Fall From Investors' Good Graces
Valeant Pharmaceuticals' Dizzying Fall From Investors' Good Graces

After Valeant, Short-Seller Citron Is Going After This Pharma Firm | Fortune
After Valeant, Short-Seller Citron Is Going After This Pharma Firm | Fortune

Short seller Fahmi Quadir Says Tesla Reminds Her of Valeant Crash -  Bloomberg
Short seller Fahmi Quadir Says Tesla Reminds Her of Valeant Crash - Bloomberg

Plunge In Valeant Pharmaceuticals Costs Top Five Shareholders, Including  Ackman, Roughly $4bn
Plunge In Valeant Pharmaceuticals Costs Top Five Shareholders, Including Ackman, Roughly $4bn

Short seller Chanos says Tesla sure does remind him of Valeant
Short seller Chanos says Tesla sure does remind him of Valeant

The short-seller who uncovered Valeant has found his next target in health  care
The short-seller who uncovered Valeant has found his next target in health care

The 'Short' Who Sank Valeant Stock - WSJ
The 'Short' Who Sank Valeant Stock - WSJ

Short seller who foresaw Valeant crash now bets on Tesla falling
Short seller who foresaw Valeant crash now bets on Tesla falling

Valeant's stock has plunged, so where are all the shorts? - The Globe and  Mail
Valeant's stock has plunged, so where are all the shorts? - The Globe and Mail

Here's how much Valeant short sellers have been killing it ever since Bill  Ackman got in the stock
Here's how much Valeant short sellers have been killing it ever since Bill Ackman got in the stock

The short seller who bet big against Valeant has turned bullish on the  company he helped bring down - The Globe and Mail
The short seller who bet big against Valeant has turned bullish on the company he helped bring down - The Globe and Mail

Valeant scandal shows why we need short-sellers in the stock market - Los  Angeles Times
Valeant scandal shows why we need short-sellers in the stock market - Los Angeles Times

Valeant Short Seller Dials Back Warning of Bombshell Report on Monday - WSJ
Valeant Short Seller Dials Back Warning of Bombshell Report on Monday - WSJ